Heron Therapeutics | HRTX - Ebitda





Ebitda Veränderung Datum
ALKERMES USD 139.22M 58.96M 2026-06
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Eisai JPY 34.15B 34.48B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Ligand Pharmaceuticals USD -14.3M 81.08M 2026-03
Merck USD -1.54B 7.84B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Veracyte USD 43.96M 1.16M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06